Translate:


NCVH Lafayette | November 16, 2013 - Cardiovascular Update for the Primary Care Provider


NCVH Lafayette

Thank you to all of the attendees, faculty members, and sponsors that participated in this year's Cardiovascular Update for the Primary Care Provider.

You will be able to download your Certificates starting November 22, 2013.

Join us for an exciting opportunity to earn CME/CE credit, benefit from networking with local peers, and enjoy a full day of great education.
 
The Cardiovascular Update for the Primary Care Provider will focus on new developments, treatments, and technology available for patients with cardiovascular disease, including Coronary Artery Disease, Structural and Valvular Heart Disease, Rhythm Management, and Peripheral Artery Disease.
 
Registration includes accreditation, breakfast, lunch, and outstanding education presented by 10+ experts in the field of cardiovascular medicine.
 
Accreditation will be provided for Physicians, Nurses, Allied Health Professionals, and Cath Lab Technologists.

If you have questions or if we can assist you in any way, please contact our foundation office at 337-993-7920 or registration@ncvh.org.


Supported by an educational grant from Daiichi Sankyo, Inc.


Agenda


Faculty

Chairmen:

Raghotham R. Patlola, MD
Cardiovascular Institute of the South
Lafayette, LA

Craig M. Walker, MD
Cardiovascular Institute of the South
Houma, LA

Please scroll to see the full list of Faculty.
After clicking on a name click "Go Back" to return to the full list.


Accreditation



Physical (paper) accreditation certificates will not be issued onsite at this conference. All certificates will be available online by Friday, November 22, 2013.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and New Cardiovascular Horizons. Global is accredited by the ACCME to provide continuing medical education for physicians.
 
Physician Credit Designation

Global Education Group designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the Cardiovascular Update for the Primary Care Provider (NCVH Lafayette).
 
Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 7.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
American Society of Radiologic Technologists

This activity is approved for credit by the ASRT.
 
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com
 
Target Audience

Family Physicians, General Practice Physicians, Primary Care Providers, Internists, Cardiologists, Interventional Cardiologists, Vascular Medicine Specialists, Podiatrists, Cath Lab Technologists, Residents/Fellows, Physician Assistants, Advanced Practice Nurses, Nurses, Allied Health Professionals and Healthcare Administrators.
 
Statement of Need/Program Overview
The Cardiovascular Update for the Primary Care Provider will focus on new developments, treatments, and technology available for patients with cardiovascular disease, including Coronary Artery Disease, Structural and Valvular Heart Disease, Rhythm Management, and Peripheral Artery Disease.
 
Educational Objectives

After completing this activity, the participant should be better able to:
 

ACS and CAD

  • Select an optimal antiplatelet therapeutic strategy for each patient based on individualized patient characteristics and risk factors.

  • Analyze updated guidelines for ACS management, highlighting the role of newly available treatment options.

  • Differentiate between each of the available P2Y12 receptor antagonists using findings from clinical trials.

AF and Stroke

  • Discuss the clinical trial findings regarding the efficacy and safety profiles of the novel oral anticoagulants for the treatment of AF and stroke prevention.

  • Design an individualized treatment approach for each AF patient taking into account their risk of stroke and bleeding, renal status, and comorbidities.

  • Evaluate the most recent AHA/ASA clinical guidelines as well as other scientific advisories regarding optimal stroke prevention in patients with AF.

Hypertension

  • Determine individualized blood pressure target goals for patients with a variety of risk factors and comorbidities.

  • Evaluate clinical data that support the use of fixed-dose combination therapies, with or without thiazide diuretics.

  • Evaluate the most recent AHA/ASA clinical guidelines as well as other scientific advisories regarding optimal stroke prevention in patients with AF.

  • Develop a strategy for incorporating JNC 7, ASH, and forthcoming JNC 2013 guidelines into your own practice.

Dyslipidemia

  • Determine individualized lipid goals for patients with a variety of secondary prevention cardiovascular risk factors

  • Analyze existing and new options for patients with treatment resistant familial hypercholesterolemia.

  • Develop a strategy for incorporating NCEP ATP III and forthcoming ATP IV guidelines into your own practice. 

Certificate Instructions
If you have any questions regarding accreditation or certificates, please visit the registration table located in the foyer outside of the meeting room. Physical accreditation certificates will not be issued at this conference. 
 
3 Easy Steps to Print Your Certificate:
1. Go to www.ncvh.org, login with your username and password (upper right corner of the website).
2. Click “Edit My Profile” and update your credentials and specialty to ensure you receive the correct certificate, click submit.
3. In your profile, locate “Lafayette 2013” and click “Complete Evaluation”. After completing the evaluation, your certificate will be available to download on the main profile page.

 
You will be asked to complete a brief survey to receive your certificate. If you have questions or need assistance, please contact us at 337-993-7920 or registration@ncvh.org.


Supported by an educational grant from Daiichi Sankyo, Inc.ertificate Instructions

 


Exhibitors / Sponsors

CLICK HERE for the 2013 Lafayette Exhibit Space Application

CLICK HERE for the 2013 Lafayette Electrical and Internet Form

 



Thank you to our Exhibitors and Sponsors at NCVH Lafayette 2013

Platinum

The Regional Medical Center of Acadiana

Gold
Aegerion Pharmaceuticals
Cook Medical 
Gilead Sciences, Inc.
Vascular Solutions


Silver
Arbor Pharmaceuticals
Bayer HealthCare 
Boston Scientific, CRM. 
Cardiovascular Systems, Inc.

Daiichi-Sankyo, Inc.
Edwards Lifesciences 
Kowa Pharmaceuticals America
Medtronic


Supporter
Abiomed
Boston Heart Diagnostics
Cardiovascular Institute of the South
Gore & Associates
Janssen Pharmaceuticals 
Lafayette General Medical Center 
Novartis Pharmaceuticals
Spectranetics


Exhibitor
Cardiva Medical
Home Sleep Delivered

 

Exhibit Levels: 
Platinum $ 3,000 
Gold $ 2,000 
Silver $ 1,500 
Supporter $ 1,000 
Discounted Rate $ 500 * 
*Available for Home Health Agencies or companies with fewer than 25 employees.

Additional Opportunities: 
Breakfast $ 2,000 
Lunch $ 3,000 
Additional Badge $ 100 
*Breakfast and lunch sponsors recognized on signage and in sponsor list.
Symposia to include non-accredited education available upon request for an additional fee.

Exhibit Details:
• Space is limited to 35 table top exhibits 
• Space cannot be reserved without full payment 
• Exhibit spaces are 6’ x 30” table tops to include table cloth, table skirt, and 2 chairs 
• Send all shipments directly to meeting location 
• Exhibit services are not provided for this meeting

Exhibit Schedule:
• Move-In: Friday, November 15 | 5:00 pm - 7:00 pm 
• Move-In: Saturday, November 16 | 7:00 am - 9:00 am 
• Exhibit Hours: Saturday, November 16 | 9:00 am - 4:30 pm 
• Move-Out: Saturday, November 16 | 5:00 pm

Meeting Location:
Hilton Lafayette
1521 West Pinhook Road
Lafayette, LA  70503

Overnight Accommmodations:
Visit the Accommodations and Travel Page for hotel information.

         

Accommodations

Hilton Lafayette
1521 West Pinhook Road
Lafayette, LA  70503
1-337-235-6111

• $89.00 per night
• Check-in: Fri November 15, 2013
• Check-out: Sun November 17, 2013
• Special rate available until: Fri October 25, 2013

For Reservations, call 800-445-8667 and reference “New Cardiovascular Horizons”.
 
The Hilton Lafayette hotel in Lafayette, LA is ideally located for exploring Lafayette’s vibrant city center, and is situated minutes from downtown.
 
Area Airport
 
Lafayette Regional Airport - LFT
 
Hilton Lafayette: 3 miles
 
Driving Directions

From I-10: take the I49/Highway 90/SW Evangeline Thwy South exit. (Exit 103A) Head south for three miles and turn right on Pinhook. Our Hilton hotel is 1.5 miles on your left.
 
Alternate Transportation
 
Hilton Lafayette offers complimentary airport shuttle service.  Please call 337-235-6111 for more information.
 
Taxis are available. Estimated taxi fare: 10.00 USD (one way).
City Cab: 337-235-7515
Dixie Cab: 337-237-3333
Reliable Taxi: 337-739-7651

Presentations

Coronary Artery Disease


8:00AM | Raghotham Patlola, MD | Craig Walker, MD
Welcome and Opening Remarks

8:10AM | Wade May, MD
Cardiovascular Risk Modification and Implementation of Heart Healthy Lifestyles: View PDF

8:25AM | Christopher Daniels, MD
Advances in Cardiovascular Imaging: View PDF

8:40AM | Jayaraman Venkatesan, MD
NSTEMI: Risk Assessment and Update on Guidelines: View PDF

8:55AM | John Patterson, MD
STEMI: Update on Guidelines and Novel Emerging Therapies: View PDF

9:10AM | Peter Fail, MD
Appropriate Use Criteria in Coronary Interventions: View PDF

9:25AM | Agostino Ingraldi, MD
Antiplatelet Therapy for Secondary Prevention of Atherothrombosis: View PDF

9:40AM | Deepak Thekkoott, MD
High Risk Coronary Angioplasty Using Novel Support Devices: View PDF

9:55AM | Craig Walker, MD
What’s New on the Vascular Horizon: View PDF

10:15AM
Questions and Answers/Panel Discussion

10:30AM
Break/Exhibits

 

Structural and Valvular Heart Disease


10:45AM | Raghotham Patlola, MD
Stenotic and Regurgitant Valvular Heart Disease: A Primer: View PDF

11:00AM | Louis Salvaggio, MD
TAVR: Indications, Techniques, Outcomes, and Results: View PDF

11:15AM | Peter Fail, MD
Percutaneous Mitral Valve Repair: View PDF

11:30AM | Charles Wyatt, MD
A Surgeon’s Perspective of Percutaneous Heart Valve Repair: View PDF

11:45AM | John Patterson, MD
Therapeutic Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: View PDF

12:00PM | Raghotham Patlola, MD
Renal Denervation: View PDF

12:15PM | Craig Walker, MD
Achievement Award Presentation: View PDF

12:20PM | Larry Hollier, MD
Keynote Address: The Shortage of Primary Care in Louisiana: Solutions!

12:30PM
Lunch/Exhibits

 

Rhythm Management


1:30PM | Richard Abben, MD
Managing Atrial Fibrillation and Ablation Therapy: View PDF

1:45PM | Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for the Treatment of Atrial Fibrillation and Prevention of Stroke
Agostino Ingraldi, MD: View PDF

2:00PM | Satish Gadi, MD
Syncope and Sudden Cardiac Death: View PDF

2:15PM | Richard Abben, MD
Advances in the Management of Congestive Heart Failure and How to Prevent Readmissions: View PDF

2:30PM | David Slovut, MD PhD
Finding Big Red: Tips and Tricks for Vascular Access: View PDF

3:00PM
Questions and Answers/Panel Discussion

3:15PM
Break/Exhibits

 

Peripheral Arterial and Venous Disease


3:30PM | Kalyan Veerina, MD
Percutaneous AAA Repair: Indications, Techniques, and Results: View PDF

3:45PM | Deepak Thekkoott, MD
Carotid Artery Disease: Stenting, Use of Embolic Protection, and the Outcomes: View PDF

4:00PM | Bose Cheeran, MD
Role of Atherectomy in Treatment of Complex Peripheral Vascular Disease: View PDF

4:15PM | Nick Cavros, MD
Innovative Techniques and New Modalities of Therapy in PAD Interventions: View PDF

4:30PM | Raghotham Patlola, MD
Endovenous Approaches to Deep Venous Thrombosis and Pulmonary Embolism: View PDF

4:45PM
Questions and Answers/Panel Discussion

4:55PM | Raghotham Patlola, MD | Craig Walker, MD
Closing Remarks

Connect and share with NCVH Online!